FDA to update AI rules, signals digital health leader
Part of composite article FDA Labels 100+ AI Devices as ‘Breakthrough’—What It Means for Patients View full article →
The U.S. Food and Drug Administration’s top digital health official has indicated that the agency plans to update its policies on artificial intelligence in medicine. The announcement came during a health tech briefing, where the official hinted at new guidance for AI-powered devices and software. The FDA has not released specific details yet, but the move signals a shift toward clearer rules for fast-evolving AI tools in healthcare. Separately, a new initiative will offer virtual physical therapy to an entire country, expanding remote care options for patients.